医学临床研究
   May. 6, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2022, Vol. 39 Issue (7): 1075-1078    DOI: 10.3969/j.issn.1671-7171.2022.07.032
OriginalArticles Current Issue | Archive | Adv Search |
Effect of Valsartan and Amlodipine on Serum ROCK1 and ROCK2 Levels in Patients with End-stage Renal Disease
CHENG Wei-ping, PEI Yuan-yuan
Department of Pharmacy,Yulin No.2 Hospital,Yulin Shaanxi 719000
Download: PDF (1154 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】 To study the clinical efficacy of valsartan and amlodipine in the treatment of end-stage renal disease (ESRD) and its effect on the level of serum Rho associated coiled coil protein kinase1 (ROCK1) and ROCK2. 【Methods】Ninety-two patients with ESRD in Yulin No.2 Hospital were randomly divided into the control group and the observation group,with forty-six cases in each group. Both groups were treated with hemodialysis,in which the control group was treated with amlodipine and the observation group was treated with valsartan and amlodipine. The curative effects of the two groups after 3 months of treatment were compared,and blood pressure level[systolic blood pressure (SBP),diastolic blood pressure (DBP)],the renal function[serum creatinine (SCR),urea nitrogen (BUN)],serum ROCK1 and ROCK2 levels,and quality of life[kidney disease and dialysis related quality of life (KDTA)] before and after 3 months of treatment were compared in both groups. The adverse reactions during treatment were counted as well. 【Results】The total effective rate in the observation group was 91.30%(42/46),which was higher than 76.09%(35/46) in the control group (P<0.05). After 3 months of treatment,DBP,SBP,SCr,BUN, and levels of serum ROCK1 and ROCK2 in the observation group were lower than those in the control group (P<0.05). The KDTA score in the observation group after 3 months of treatment was higher than that in the control group (P<0.05). The incidence of adverse reactions was 17.39%(8/46) in the observation group and 13.04%(6/46) in the control group. There was no significant difference between the groups (P>0.05). 【Conclusion】Valsartan and amlodipine are effective in the treatment of ESRD. They can lower blood pressure,improve renal function,reduce the levels of serum ROCK1 and ROCK2,improve the quality of life,have high safety,and can be popularized in clinic.
Key wordsAmlodipine, Valsartan Drug Combination/PD      Nephrosis/DT      rho-Associated Kinases/BL      Treatment Outcome     
Received: 17 January 2022     
PACS:  R692  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
CHENG Wei-ping
PEI Yuan-yuan
Cite this article:   
CHENG Wei-ping,PEI Yuan-yuan. Effect of Valsartan and Amlodipine on Serum ROCK1 and ROCK2 Levels in Patients with End-stage Renal Disease[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(7): 1075-1078.
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.07.032     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I7/1075
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech